Stevanato Group S.p.A.

STVN · XNYS

CIK 1849853fmd_189PYTJWBKR9YPKYJ37TJPK9QJManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2019 to Dec 31, 2025, 7 periods

Income Statement · Annual · Millions · EUR
Line item	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	537	662	844	984	1,085	1,104	1,186
Cost of revenue	399	468	579	664	745	802	842
Gross profit	138	194	265	320	340	302	344
Research and development	8	17	30	34	36	32	25
Operating income	62	103	162	192	201	161	199
Interest expense	15	22	19	30	18	14	23
Income before taxes	55	96	166	188	190	160	189
Income tax expense	16	18	31	45	44	43	49
Net income from continuing operations	39	79	134	143	146	118	140
Net income	39	79	134	143	146	118	140
Net income to common shareholders	39	79	134	143	146	118	140